Development and Validation of the Patient-completed Caprini Risk Score
NCT ID: NCT04663477
Last Updated: 2020-12-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1017 participants
OBSERVATIONAL
2019-01-01
2021-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Trained nurse-completed CRS
patient-completed Caprini Risk Score
The participants will be asked to complete patient-completed Caprini Risk Score
Patient-completed CRS
patient-completed Caprini Risk Score
The participants will be asked to complete patient-completed Caprini Risk Score
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
patient-completed Caprini Risk Score
The participants will be asked to complete patient-completed Caprini Risk Score
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with first admission to the medical and surgical units within 24 hours
* willingness to participate in the study
Exclusion Criteria
* patients with cognitive impairment
* inability to read or write
* patients with mental diseases
* patients with visual impairment
* refusal to cooperate
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
China-Japan Friendship Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zhenguo Zhai,MD,PhD
Deputy Director of the Second Department of Respiratory and Critical Care Medicine in China-Japan Friendship Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
China-Japan Frendship hospital
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Zhenguo Zhai, Ph D
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
VTE-CRS-study
Identifier Type: -
Identifier Source: org_study_id